Gilead Sciences

Is trending stock Gilead Sciences, Inc. (GILD) a buy now? Zacks15:08Pharma

Gilead's HIV drugs power earnings beat, company eyes multiple launches by 2026 Benzinga17:56Pharma

Gilead's Trodelvy misses main goal in breast cancer study but shows early survival trend Benzinga15:40Global Health Stock Markets (World) Stock Market

STAT Plus: Why one expert thinks Gilead can produce a $25 HIV prevention shot, help eradicate… STAT14:27HIV Biotech Pharma

STAT Plus: CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV… STAT15:16HIV Biotech Pharma

STAT Plus: Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs STAT17:46HIV AIDS Pharma

Is Wall Street bullish or bearish on Gilead Sciences stock? Barchart09:51Wall Street Stock Market (US) Stock Market

Gilead Sciences (NASDAQ:GILD) exceeds Q3 expectations Barchart20:48Wall Street Stock Market (US) Stock Market

Gilead Sciences (GILD) Q3 earnings and revenues top estimates Zacks22:19GILD Pharma

Gilead (GILD) reports Q3 earnings: What key metrics have to say Zacks23:31GILD Pharma

CVS tells HIV activists that pharma company Gilead needs to lower price of PrEP drug if it wants it covered Advocate.com18:12HIV Pharma Protest Issues

Latest News

Yesterday

FCA Dismissal Illustrates Pharmaceutical Promotion Done Right Drug & Device Law10:05 10-Nov-25

Ahf’s Mobile Billboard Calls Out Gilead’s Greed at Pharma Summit Business Wire (Press Release)09:10 10-Nov-25

In the last 7 days

Invesco S&P 500 Quality ETF Experiences Big Outflow Nasdaq16:13 7-Nov-25

Gilead's Trodelvy Misses Main Goal In Breast Cancer Study But Shows Early Survival Trend Benzinga15:40 7-Nov-25

STAT Plus: Why one expert thinks Gilead can produce a $25 HIV prevention shot, help eradicate… STAT14:27 7-Nov-25

Gilead Provides Update on Phase 3 ascent-07 Study Business Wire (Press Release)13:33 7-Nov-25

Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (Pbc),… Business Wire (Press Release)13:03 7-Nov-25

Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now? Zacks15:08 5-Nov-25

Gilead's Vemlidy now reimbursed as initial therapy for chronic hepatitis B in Korea Korea Biomedical Review07:02 5-Nov-25

Gilead Sciences to Present at Upcoming Investor Conferences Business Wire (Press Release)21:05 4-Nov-25

In the last month

Gilead and Kite Showcase Continued Progress in Transforming Blood Cancer Care With New Cell… Business Wire (Press Release)14:19 3-Nov-25

Gilead Sciences’ Earnings Call Highlights Growth and Optimism TipRanks00:16 1-Nov-25

Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026 Benzinga17:56 31-Oct-25

Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product… Business Wire (Press Release)12:08 31-Oct-25

Is Wall Street Bullish or Bearish on Gilead Sciences Stock? Barchart09:51 31-Oct-25

Gilead Sciences Reports Strong Q3 2025 Results TipRanks04:15 31-Oct-25

Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say Zacks23:31 30-Oct-25

Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates Zacks22:19 30-Oct-25

Gilead Sciences (NASDAQ:GILD) Exceeds Q3 Expectations Barchart20:48 30-Oct-25

Mich. Top Court Upholds Gilead Immunity In COVID Drug Case Law36020:22 30-Oct-25

Snoop Dogg Partners With Glaad To Bring HIV Awareness To Hbcu Campus Black Enterprise18:33 30-Oct-25

Victory! Ahf, 100 Organizations Kill Gilead’s Greedy Drug Price Hikes Business Wire (Press Release)20:16 29-Oct-25

A Glimpse of Gilead Sciences's Earnings Potential Benzinga14:18 29-Oct-25

Gilead Sciences’ GS-1219 HIV Study Update: Implications for Investors TipRanks16:42 27-Oct-25

Curious about Gilead (GILD) Q3 Performance? Explore Wall Street Estimates for Key Metrics Zacks14:21 27-Oct-25

CVS tells HIV activists that pharma company Gilead needs to lower price of PrEP drug if it wants it covered Advocate.com18:12 24-Oct-25

Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period… PR Newswire (Press Release)22:39 23-Oct-25

Gilead to Showcase Interim Long-Term Efficacy Data for Livdelzi® (Seladelpar) in Primary… Business Wire (Press Release)13:01 23-Oct-25

Gilead Sciences (GILD) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks00:09 23-Oct-25

Ipsen Boosts Cancer Pipeline With ImCheck Buy Scrip Pharma Intelligence16:02 22-Oct-25

STAT Plus: CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV… STAT15:16 22-Oct-25

What to Expect From Gilead Sciences' Next Quarterly Earnings Report Barchart14:04 22-Oct-25

Health Canada conditionally approves Gilead Sciences’ Lyvdelzi for PBC Pharmaceutical Technology09:36 22-Oct-25

STAT Plus: Gilead agrees not to raise prices on HIV medicines for state AIDS drug programs STAT17:46 21-Oct-25

Pharma giants race to treat tough triple-negative breast cancer The Seattle Times14:18 21-Oct-25

Ahf: 80 Organizations Denounce Gilead on Price Hikes Gutting Adap Business Wire (Press Release)11:34 21-Oct-25

Broader access urged for affordable HIV drug SciDev.Net02:15 21-Oct-25

AstraZeneca, Gilead vie for edge in race to treat tough breast cancer The Economic Times20:00 20-Oct-25

ESMO 25: Trodelvy And Datroway Take Up Positions In TNBC Tussle Scrip Pharma Intelligence18:04 20-Oct-25

Gilead Sciences Completes Promising Study on Metastatic Colorectal Cancer Treatment TipRanks17:38 20-Oct-25

Gilead to Spotlight New Virology Data Across HIV, Viral Hepatitis and Respiratory Diseases at… Business Wire (Press Release)13:30 19-Oct-25

STAT Plus: At ESMO, AstraZeneca, Gilead square off in triple-negative breast cancer STAT10:20 19-Oct-25

Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line … Business Wire (Press Release)07:33 19-Oct-25

Raheem DeVaughn Announces His “20 Lessons Of Love” Tour YouKnowIGotSoul22:05 17-Oct-25

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know Zacks15:07 16-Oct-25

Gilead to present data on potential first weekly oral treatment for HIV Clinical Trials Arena08:50 16-Oct-25

Tubulis Tunes Up For ESMO With €308m Series C Scrip Pharma Intelligence10:37 15-Oct-25

Gilead Presents New HIV Research Data at Eacs 2025 – Driving Scientific Innovation in Treatment … Business Wire (Press Release)08:31 15-Oct-25

Gilead Sciences/Arcus Biosciences' Investigational Cancer Drug Shows Overall Survival Of Around 27 Months Benzinga15:48 13-Oct-25

Gilead, Coinbase, Rocket Lab And A Tech Stock On CNBC's 'Final Trades' Benzinga13:37 13-Oct-25

Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at Esmo 2025 Business Wire (Press Release)13:36 13-Oct-25

view more headlines

10 Nov 10:05

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.